(Stroke. 2000;31:2966.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the East Carolina University Anticoagulation Clinic (C.A.E., M.M.H.); Brody School of Medicine at East Carolina University (V.B.H., C.C., J.C.B.); and the Clinical Information Support Office, University Health Systems (C.A.E.), Greenville, North Carolina.
Correspondence to Dr Carlos Estrada, Brody School of Medicine at East Carolina University, 600 Moye Boulevard, PCMH TA-389, Greenville, NC 27858-4353. E-mail estradac{at}mail.ecu.edu
BackgroundWarfarin therapy requires frequent monitoring and dose adjustment. Elderly patients with atrial fibrillation, prior stroke, and lower literacy skills may have difficulty reading brochures that explain dosing instructions, procedures to follow, and the risks and benefits of anticoagulants. In general, it is recommended that brochures be written at or below the 6th-grade level. We determined the readability of patient information material being offered to patients receiving anticoagulants.
Methods and ResultsWe used the SMOG grade formula to measure readability of written patient materials. We obtained 50 brochures commonly used in anticoagulation management units from industry and health advocacy groups. Patient information was related to atrial fibrillation (16%, n=8), warfarin (44%, n=22), low-molecular-weight heparins (12%, n=6), or other related topics (28%, n=14). The mean readability was found to be grade 10.7 (95% CI 10.1 to 11.2); none had a readability score at the 6th-grade level or below, 12% of the brochures had readability scores at the 7th- to 8th-grade levels (n=6), 74% at the 9th- to 12th-grade levels (n=37), and 14% at higher than 12th-grade level (n=7). The readability grade level was similar for brochures produced by industry or health advocacy groups (P=0.9) but higher for information obtained from the Internet (12.2±1.3 grades) compared with other sources (10.3±2.1 grades; P=0.01).
ConclusionsPatient education materials related to the use of anticoagulants are written at grade levels beyond the comprehension of most patients. Low-literacy brochures are needed for patients on anticoagulants.
Key Words: anticoagulants deep vein thrombosis health education patient compliance stroke prevention
This article has been cited by other articles:
![]() |
W. H. Shrank and J. Avorn Educating Patients About Their Medications: The Potential And Limitations Of Written Drug Information Health Aff., May 1, 2007; 26(3): 731 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Shrank, J. Avorn, C. Rolon, and P. Shekelle Effect of Content and Format of Prescription Drug Labels on Readability, Understanding, and Medication Use: A Systematic Review Ann. Pharmacother., May 1, 2007; 41(5): 783 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Birman-Deych, M. J. Radford, D. S. Nilasena, and B. F. Gage Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation Stroke, April 1, 2006; 37(4): 1070 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. McCray Promoting Health Literacy J. Am. Med. Inform. Assoc., March 1, 2005; 12(2): 152 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E Ferner Is concordance the primrose path to health? BMJ, October 11, 2003; 327(7419): 821 - 822. [Full Text] [PDF] |
||||
![]() |
S. Nadar, N. Begum, B. Kaur, S. Sandhu, and G. Y H Lip Patients' understanding of anticoagulant therapy in a multiethnic population J R Soc Med, April 1, 2003; 96(4): 175 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M Koo, I. Krass, and P. Aslani Factors Influencing Consumer Use of Written Drug Information Ann. Pharmacother., February 1, 2003; 37(2): 259 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Eysenbach, J. Powell, O. Kuss, and E.-R. Sa Empirical Studies Assessing the Quality of Health Information for Consumers on the World Wide Web: A Systematic Review JAMA, May 22, 2002; 287(20): 2691 - 2700. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |